Human CFHR5 quantitates human CFHR5 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CFHR5.
Human CFHR5 quantitates human CFHR5 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CFHR5.
This gene is part of a small group of H-factor genes (CFH) of chromosome 1 complement. Each member of this gene family contains several short consensus repeats (SCRs) typical of complement activation regulators. The protein encoded by this gene has nine SCRs with the first two repeats having heparin bonding properties, one region in repeats 5-7 with reactive protein binding heparin and C-linking properties and the C-terminal repeats being similar to a 3b (C3b) complementary binding domain. This protein co-located with C3, binds C3b in a dose-dependent manner and is recruited into tissue damaged by C-reactive protein. Allelic variations of this gene were associated, but not related to the cause, with two different forms of renal disease: glomerulonephritis type II membranoproliferative (MPGNII) and hemolytic uremic syndrome (HUS).
Sensitivity
Sensitivity of the assay: 0.41 ng/mL.
Measurement range
Dose range: 0.41 to 100 ng/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (plasma volume, 50 µl; Serum, 50 µl; Supernatant, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17154849 |
| Specifications |
| Accession number | CFHL5; CFHR5; CFHR5D; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5; supplement to factor H 5 to factor H 5; supplement to factor H 5 to factor H 5; supplement factor H 5 to factor H 5; supplement H 5; supplement factor H 5 to factor H 5 to factor H 5; supplement H to factor H 5; supplement H to factor H to factor H 5; supplement H 5 to factor H to factor H 5; supplement H to H to H to factor H to factor H 5; supplement H FHR5; FHR-5 |
| Dose range | 0.41 to 100 ng/mL |
| Sensitivity of the dosage | 0.41 ng/mL |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | Q9BXR6 |
| Gene symbol(s) | CFHR5 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | Pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | CFHR5 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 µl; Serum, 50 µl; Supernatant, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH104RBX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.